1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. Company
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
Delayed Nasdaq Helsinki  -  07:49 2022-08-10 am EDT
3.570 EUR   -3.38%
04:01aInvitation to Nanoform's Interim Report January-June 2022
AQ
07/14Nanoform and Pharmanovia to breathe new life into iconic medicines
AQ
07/14Nanoform Finland Plc Partners with Pharmanovia for Iconic Medicines
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Nanoform Finland Oyj is a Finland-based limited liability Company offering services in nanotechnology and drug particle engineering for the international pharma industry. The Company’s affairs consist of both internal research and development activities and proof of concept type of research and development services provided to customers.

Number of employees : 125 people.
Sales per Business
20202021Delta
Nanotechnology and Drug Particle Engineering0.69100%1.95100% +184.61%
EUR in Million
Sales per region
20202021Delta
Europe0.5579.6%1.5679.7% +184.88%
United States0.1420.4%0.4020.3% +183.57%
EUR in Million
Managers
Name Title Age Since
Edward Hæggström, Dr. Chief Executive Officer 52 2015
Albert Häggström Chief Financial Officer & Director - 2018
Niklas Sandler, Dr. Chief Technology Officer 49 2019
Gonçalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations - 2019
Henri von Haartman Director-Investor Relations - 2019
David Rowe, Dr. Head-Manufacturing 54 2019
Christian Jones Chief Commercial Officer - 2018
Peter Hänninen General Counsel - 2020
Johanna Tuomisto Director-Human Resources - 2021
Members of the board
Name Title Age Since
Miguel Maria de Oliveira Barreiros Calado Chairman 65 2020
Mads Laustsen Vice Chairman 64 2020
Albert Häggström Chief Financial Officer & Director - 2018
Jeanne A. Thoma Director 61 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,280,464 58,440,529 74.7% 0 0.0% 74.7%
Shareholders
NameEquities%
Edward Hæggström 5,409,405 6.91%
Handelsbanken Fonder AB 5,363,606 6.85%
Helsingin Yliopiston Rahastot 4,397,719 5.62%
Mandatum Henkivakuutusosakeyhtiö Oy 4,296,679 5.49%
DNB Asset Management AS 4,042,158 5.16%
Fjärde AP-fonden 3,140,050 4.01%
Keskinäinen Työeläkevakuutusyhtiö Varma 2,846,996 3.64%
Kai Falck 2,700,000 3.45%
Jouko Yliruusi 2,700,000 3.45%
Avohoidon Tutkimussäätiö sr 2,638,737 3.37%
Company contact information
Nanoform Finland Oyj
Cultivator II
Viikinkaari 4
Helsinki, Uusimaa 00790

Phone : +358.29.3700150
Web : http://www.nanoform.fi
Brand Portfolio
In partnership withAllbrands.markets
More brands of Nanoform Finland Oyj
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ-43.85%296
JOHNSON & JOHNSON-0.52%447 434
ELI LILLY AND COMPANY9.70%287 922
PFIZER, INC.-16.05%279 310
ROCHE HOLDING AG-16.02%275 991
ABBVIE INC.3.58%247 976
NOVO NORDISK A/S4.27%238 658
MERCK & CO., INC.16.81%226 779
ASTRAZENECA PLC24.94%203 058
NOVARTIS AG3.71%190 668
BRISTOL-MYERS SQUIBB COMPANY18.36%160 059
AMGEN INC.10.40%132 855
SANOFI7.79%122 268
GSK PLC0.20%80 582
BAYER AG10.98%52 412
DAIICHI SANKYO CO., LTD.23.11%51 146
CHUGAI PHARMACEUTICAL CO., LTD1.29%46 111
TAKEDA PHARMACEUTICAL COMPANY LIMITED19.48%42 938
JIANGSU HENGRUI MEDICINE CO., LTD.-26.39%35 264
ASTELLAS PHARMA INC.9.25%27 665
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-32.20%26 482